ANCA pattern and LTA haplotype relationship to clinical responses to anti-TNF antibody treatment in Crohn's disease.

Abstract

BACKGROUND & AIMS In the clinical trial, a lower response to infliximab was observed in some patients after multiple infusions, suggesting that clinical subgroups of Crohn's disease (CD) exist based on response to anti-tumor necrosis factor (anti-TNF). The aim of this study was to characterize these subgroups further by antineutrophil cytoplasmic antibody… (More)

Topics

Cite this paper

@article{Taylor2001ANCAPA, title={ANCA pattern and LTA haplotype relationship to clinical responses to anti-TNF antibody treatment in Crohn's disease.}, author={Kent D. Taylor and Scott Eric Plevy and H Yang and Carol J. Landers and Michael J. Barry and J I Rotter and Stephan Raoul Targan}, journal={Gastroenterology}, year={2001}, volume={120 6}, pages={1347-55} }